Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First Benelux Joint Pricing and Reimbursement Pilot Fails Over Vertex’ Orkambi

Executive Summary

The first pilot for the Benelux joint pricing and reimbursement process has failed. Negotiations between Vertex and the ministries of health in Belgium and the Netherlands have ended with no agreement on price for cystic fibrosis drug Orkambi.

You may also be interested in...



Compulsory Licensing And Compounded Orkambi: Solutions For Excessive Prices In The Netherlands?

Compulsory licensing, new R&D models, and pharmaceutical compounding are among measures that could help secure lower drugs prices, according to a report from the Dutch Council for Public Health and Society.

France In Talks With BeNeLuxA Access To Meds Coalition; Group Plans Expansion Beyond EU

The BeNeLuxA collaboration for sustainable access to medicines may soon expand further. Future partners could include France and non-EU markets.

New BeNeLuxA Access To Meds Initiative Pilots Are Under Way

Two new BeNeLuxA pilots are underway and a website detailing information about the wider initiative is likely to go live soon.

Related Content

Topics

UsernamePublicRestriction

Register

PS063835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel